These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Golling P; Cozzio A; Dummer R; French L; Kempf W Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Wilcox RA Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management. Wilcox RA Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037 [TBL] [Abstract][Full Text] [Related]
8. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895 [TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985 [TBL] [Abstract][Full Text] [Related]
10. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry. Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409 [TBL] [Abstract][Full Text] [Related]
11. Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire. Koning MT; Quinten E; Zoutman WH; Kiełbasa SM; Mei H; van Bergen CAM; Jansen P; Vergroesen RD; Willemze R; Vermeer MH; Tensen CP; Veelken H J Invest Dermatol; 2019 Oct; 139(10):2195-2203. PubMed ID: 31042459 [TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment. Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705 [TBL] [Abstract][Full Text] [Related]
13. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis. Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486 [TBL] [Abstract][Full Text] [Related]
15. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma. Koens L; Vermeer MH; Willemze R; Jansen PM Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823 [TBL] [Abstract][Full Text] [Related]
16. Coincidence of cutaneous follicle center lymphoma and diffuse large B-cell lymphoma. van Tuyll van Serooskerken AM; Mosterd K; Veraart JC; Vermeer MH; Frank J; van Marion AM Int J Dermatol; 2008 Nov; 47 Suppl 1():21-4. PubMed ID: 18986480 [TBL] [Abstract][Full Text] [Related]
17. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management. Wilcox RA Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008 [TBL] [Abstract][Full Text] [Related]
19. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Kutzner H; Kerl H; Pfaltz MC; Kempf W Am J Surg Pathol; 2009 Sep; 33(9):1307-13. PubMed ID: 19718787 [TBL] [Abstract][Full Text] [Related]
20. The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma. Demirkesen C; Tüzüner N; Esen T; Lebe B; Ozkal S Leuk Res; 2011 Sep; 35(9):1269-72. PubMed ID: 21700336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]